Cellular senescence-A barrier against tumor development?

Seminars in Cancer Biology

Volumn 21, Issue 6, 2011, Pages 347-348

  Larsson, Lars Gunnar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PROTEIN P16; PROTEIN P21; TELOMERASE;

APOPTOSIS; CARCINOGENESIS; CELL AGING; CELL CYCLE ARREST; CELL VIABILITY; CELLULAR STRESS RESPONSE; DNA DAMAGE; EDITORIAL; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GENE FUNCTION; HUMAN; NONHUMAN; ONCOGENE MYC; PATHOGENESIS; PHENOTYPE; TISSUE REPAIR; TUMOR SUPPRESSOR GENE;

CELL AGING; HUMANS; NEOPLASMS;

EID: 82755187524     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2011.11.001     Document Type: Editorial

References (5)

1. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Experimental Cell Research 1961, 25:585-621.
2. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602.
3. Collado M., Serrano M. Senescence in tumours: evidence from mice and humans. Nature Reviews. Cancer 2010, 10:51-57.
4. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. The essence of senescence. Genes & Development 2010, 24:2463-2479.
5. Nardella C., Clohessy J.G., Alimonti A., Pandolfi P.P. Pro-senescence therapy for cancer treatment. Nature Reviews. Cancer 2011, 11:503-511.